Skip to main content
. 2020 Oct 29;2020(10):CD001892. doi: 10.1002/14651858.CD001892.pub5

ESGCMCRF 2 1990.

Study characteristics
Methods
  • Study design: parallel RCT (554 assessed for eligibility; 336 randomised); stratified before randomisation into two groups

    • GFR < 20 mL/min/1.73 m2; run‐in for three months to demonstrate declining GFR

  • Study duration: date of first recruitment not stated. Last follow up September 1991

  • Study follow‐up period: about 50 months

Participants
  • Countries: Italy, Germany, Sweden

  • Setting: multicentre (number of sites not reported)

  • Patients with GFR < 20 to 60 mL/min/1.73 m2; run‐in for 3 months

  • Number: very low protein diet group (99); low protein diet group (103)

  • Mean age: 50 years

  • Sex (M:F ratio): 1.4:1

  • Exclusion criteria: stable GFR during run‐in period

Interventions Very low protein diet group
  • Prescribed protein intake: 0.3 g/kg/day protein + amino acid/keto acid supplement

  • Median calculated protein intake: 0.35 g/kg/day during 1 year


Low protein diet group
  • Prescribed protein intake: 0.6 g/kg/day protein

  • Median calculated protein intake: 0.56 g/kg/day during 1 year


Co‐interventions
  • All groups received 35 Kcal/kg/day

Outcomes
  • ESKD measured by number commencing dialysis

Notes
  • Funded by grant from Bundesministerium fȕr Forschung und Technologie

  • Primary endpoint of reports was dietary compliance

  • No report of final study results identified

  • Fewer than 50 of 554 assessed for eligibility had diabetic kidney disease

  • Information on sequence generation and allocation concealment kindly provided by Professor Norbert Gretz

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Block randomisation scheme for each centre
Allocation concealment (selection bias) Low risk Sealed and numbered envelopes
Blinding of participants and personnel (performance bias)
All outcomes High risk Not blinded and lack of blinding may influence patient management
Blinding of outcome assessment (detection bias): End or change in GFR
End of change in GFR Unclear risk No information provided. Outcome not reported in this study
Blinding of outcome assessment (detection bias): Need to start dialysis
Need to start dialysis Unclear risk Unclear how end point of the onset of ESKD and the need for dialysis was determined
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Not clear whether data on all participants were reported
Selective reporting (reporting bias) High risk No report of death or GFR; medians of BMI only available
Other bias Low risk Grant from Bundesministerium für Forschung und Technologie, FRG (No. 0704743)